The biallelic inactivation of the KEAP1 gene was reported to have a great impact on the upregulation of NRF2 and was firstly described in non small cell lung cancer (NSCLC) and then widely notified in many other solid tumors [36,37,38,39]. The gene discussed is KEAP1; the disease is non-small cell lung carcinoma.